Header cover image

Swiss Pharmaceuticals & Biotech Small Cap High Growth Stocks

UPDATED Jul 23, 2022

Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.

4 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
NWRNNewron PharmaceuticalsCHF1.444.3%-37.4%CHF25.7mCHF9.25PS4.5xE54.6%n/a
BSLNBasilea PharmaceuticaCHF40.103.6%-12.2%CHF475.1mCHF68.29PS3.2xE52.8%0%
SANNSanthera Pharmaceuticals HoldingCHF0.85-3.9%-63.7%CHF44.1mCHF5.50PB33.2xE67.5%n/a
ADXNAddex TherapeuticsCHF0.2549.4%-83.2%CHF9.6mn/aPS3.9xE34.8%n/a
Page 1 of 1